TrialProceedings of the National Academy of Sciences of the United States of America2010

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine.

William Blum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.